NSEUpdates6d ago · 14 Oct 2026, 05:42 pm

Updates

Suraksha Diagnostic Limited · SURAKSHA

✦ AI SummaryRegulatory

Suraksha Diagnostic Limited has informed the Exchange regarding 'Board Comments on the Delay in Filing of the Shareholding Pattern with the National Stock Exchange of India Limited (NSE)'. The Board took note of the non-compliance and advised the Secretarial team to exercise utmost care and diligence in ensuring timely submission of all statutory and regulatory filings. The Company remains committed to maintaining high standards of corporate governance and regulatory compliance.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suraksha Diagnostic Limited has informed the Exchange regarding 'Board Comments on the Delay in Filing of the Shareholding Pattern with theNational Stock Exchange of India Limited (NSE)'.

Attachments (1)

📄

SURAKSHA_14102026174221_Suraksha_Outcome_of_Board_Meeting_14-09-2026.pdf

pdf

Download →
View document text
Date: 14th October, 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA Dear Sir / Ma’am, Sub: Board Comments on the Delay in Filing of the Shareholding Pattern with the National Stock Exchange of India Limited (NSE) Ref: Notice bearing Ref. No. NSE/LIST/C/2026/0977 dated August 31, 2026 issued by NSE Pursuant to the above-mentioned NSE Notice (enclosed herewith as Annexure – I) and in accordance with the provisions of the SEBI Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 (“Master Circular”) issued on July 11, 2023 and last updated on January 30, 2026, we hereby inform you that the Board of Directors of the Company (“Board”), at its meeting held on Wednesday, 14th October, 2026, considered and took note of the following: 1. The Board was apprised that the Company had received a notice dated 31st August, 2026, bearing reference no. NSE/LIST/C/2026/0977 from the National Stock Exchange of India Limited (NSE), intimating the Company of non-compliance with Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). 2. The aforesaid non-compliance pertained to delay of 1 (one) day in the submission of the Shareholding Pattern for the quarter ended 30th June, 2026, on the NSE platform, resulting in the levy of a fine in accordance with SEBI Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated July 11, 2023 (last updated on January 30, 2026). 3. Pursuant to the aforesaid Notice, the Board was further informed that NSE had directed the Company to place the matter of non-compliance and the consequential action taken by the Exchange before the Board at its next Board Meeting and thereafter communicate the Board’s comments to the Exchange. 4. The Board took note of the aforesaid non- compliance and remedial measures undertaken by the Company, including payment of the fine levied by the Exchange upon receipt of the notice. Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 Board Comments: The Board was apprised of the circumstances that led to the delay in submission of the Shareholding Pattern for the quarter ended 30th June, 2026. It was further informed that the Secretarial team had taken remedial measures to ensure timely compliance and avoid recurrence of such delays. . After due consideration, the Board took note of the non-compliance and advised the Secretarial team to exercise utmost care and diligence in ensuring timely submission of all statutory and regulatory filings. The Board further emphasised the need to strengthen internal monitoring mechanisms and compliance controls to minimise the risk of recurrence of such instances. The Company remains committed to maintaining high standards of corporate governance and regulatory compliance and is taking appropriate steps to strengthen its internal compliance framework. A copy of the NSE Notice and the communication setting out the decision taken by the Exchange are enclosed herewith as Annexure I. The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026. Please note that the meeting commenced at 04:30 P.M.(IST) and concluded at 04:40 P.M. (IST). You are requested to take the same on record. Thanking you. For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Encl.: as above Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 The requisite details required pursuant to SEBI Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January, 2026 are as under: Sr. Particulars Details 1 Name of the authority; National Stock Exchange of India Limited 2 Details of fines, penalties, Fine of Rs. 2,360 dues etc. including (Fine of Rs. 2,000 + GST of Rs. 360 amount; 3 Due date of payment; Within 15 days from the date of receipt of the Communication. The fine has already been paid on 29th September 2026 4 Reasons for delay or Not Applicable default in payment; 5 Impact on financial, No impact on the financial operations or other operation or other activities of the Company. activities of the listed entity, quantifiable in monetary terms to the extent possible. Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750 NSE/LIST/C/2026/0977 August 31, 2026 The Promoter(s) Suraksha Diagnostic Limited Dear Sir/Madam, Subject: Reminder before freezing of Promoters Holdings for non-compliance with SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 (“Listing Regulations”) Your attention is drawn towards SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 (“Master Circular”) issued on July 11, 2023 and last updated on January 30, 2026 specifying Standard Operating Procedure for imposing fines and suspension of trading in case the non-compliance with Listing Regulations is continuing and/or repetitive. It is hereby informed that your Company has not made the required submission as per Listing Regulations to the Exchange and/or not paid the fine amount levied for observed non-compliance till date. In view of the identified non-compliance/delayed compliance, the total fine payable by your Company and the particulars about manner in which fine should be remitted to the Exchange is enclosed as Annexure. As per aforesaid Master circular, if the non-compliant listed entity fails to ensure compliance with respective regulations and/or make the payment of fines within 15 days from the date of exchange notice, then the Exchange is duty bound to freeze the entire shareholding of the promoters in the Company as well as in other securities held in the demat account of the promoter till further notice. Your Company has failed to ensure compliance and/or make the payment of fines. In view of the same, this is the final reminder to ensure compliance with identified regulation and/or payment of fines within 10 days from the date of this letter, failing of which the Exchange will initiate freezing of promoter holdings as per above mentioned Master circular. Further, as per Master Circular, your Company is also required to ensure that the said non-compliance which has been identified by the Exchange and subsequent action taken by the Exchange in this regard shall be placed before the Board in the next Board Meeting and comments made by the Board shall be duly informed to the Exchange at the below mentioned path in NEAPS portal along with this letter for dissemination having the announcement text as ‘Board comments on fine levied by the Exchange’. Path: NEAPS > COMPLIANCE > Announcements > Announcements/ CA (Subject: Updates) Yours faithfully For National Stock Exchange of India Limited Sonam Yadav Manager This Document is Digitally Signed Signed by: Sonam Yadav Date: Mon, Aug 31, 2026 20:43:31 IST Location: NSE Sr. No. Name of Promoter(s) 1. Satish Kumar Verma 2. Somnath Chatterjee 3. Ritu Mittal This Document is Digitally Signed Signed by: Sonam Yadav Date: Mon, Aug 31, 2026 20:43:31 IST Location: NSE Annexur [Showing first 8,000 characters — download PDF for full document]